Sirtex Medical Inc. specializes in innovative oncology solutions, focusing on the treatment of liver cancer. The company’s core product, SIR-Spheres Y-90 resin microspheres, provides a radioactive treatment option for patients with inoperable liver cancer. Sirtex Medical serves a global market, offering advanced medical technologies to improve patient outcomes and enhance the quality of life for those affected by liver cancer.
Sirtex Medical has made significant strides in the field of oncology, with its SIR-Spheres Y-90 resin microspheres being widely recognized and utilized in the medical community. The company’s impact is evident through its extensive global reach and the adoption of its treatment solutions by healthcare providers worldwide. Sirtex Medical continues to innovate and lead in the development of effective cancer treatments, contributing to advancements in medical care and patient health.
